Schizophrenia practice guidelines: International survey and comparison

British Journal of Psychiatry

Volumn 187, Issue SEPT., 2005, Pages 248-255

  Gaebel, Wolfgang ^a   Weinmann, Stefan ^b   Sartorius, Norman ^c   Rutz, Wolfgang ^d   McIntyre, John S ^e  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e UNITY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

EUROPE; HUMAN; PRACTICE GUIDELINE; PSYCHOTHERAPY; REVIEW; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; EVIDENCE-BASED MEDICINE; HEALTH SERVICES RESEARCH; HUMANS; PRACTICE GUIDELINES; SCHIZOPHRENIA;

EID: 24944521199     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.187.3.248     Document Type: Review

References (40)

1. AGREE Collaboration (2003) Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Quality and Safety in Health Care, 12, 18-23.
2. Aldrich, R., Kemp, L., Williams, J. S., et al. (2003) Using socioeconomic evidence in clinical practice guidelines. BMJ. 327, 1283-1285.
3. American Psychiatric Association (1997) Practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry, 154, 1-63.
4. Apiquian, R., Fresan, A., Fuente-Sandoval, C., et al. (2004) Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns. Biomed Central Psychiatry, 4, 12.
5. Buitelaar, J. K., van Ewijk, W. M., Harms, H. H., et al. (1998) Antipsychoticagebruik bij Schizofrene Psychosen. Amsterdam: Nederlands Vereiniging voor Psychiatrie.
6. Canadian Psychiatric Association (1999) Canadian clinical practice guidelines for the treatment of schizophrenia. Canadian Journal of Psychiatry, 43 (suppl. 2), 25S-40S.
7. Collège des Médecins du Québec (1999) Treating Schizophrenia. http: //www.cmq.org/uploadedFiles/ lignestraitementschizophrenieang99.pdf
8. Expert Consensus Panel (2003) Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Journal of Clinical Psychiatry, 64 (suppl. 12), 2-97.
9. Gaebel, W. Falkai, P. (eds) (1998) Behandlungsleitlinie Schizophrenie. Darmstadt: Steinkopff.
10. Goldberg, D., Sharp, D. & Nanayakkara, K. (1995) The field trial of the mental disorders section of ICD-10 designed for primary care (ICD10-PHC) in England. Family Practice, 12, 466-473.
11. Grimshaw, J. M., Thomas, R. E., MacLennan, G., et al. (2004) Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technology Assessment, 8, 1-72.
12. Hamilton, S. H., Revicki, D. A., Edgell, E. T., et al. (1999) Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trial. Pharmacoeconomics, 15, 469-480.
13. Hayward, R. S., Wilson, M. C., Tunis, S. R., et al. (1995) Users' guides to the medical literature. VIII. How to use clinical practice guidelines. A. Are the recommendations valid? The Evidence Based Medicine Work Group. JAMA, 274, 570-574.
14. Jablensky, A., Sartorius, N., Ernberg, G., et al. (1992) Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychological Medicine Monograph Supplement, 20, 1-97.
15. Katschnig, H., Donat, H., Fleischhacker, W. W., et al. (2002) 4 × 8 Empfehlungen zur Behandlung von Schizophrenie. Linz: Edition Pro Mente.
16. Kovess, V., Caroli, F., Durocher, A., et al. (1994) Stratégies Thérapeutiques à Long Terme dans les Psychoses Schizophréniques. Paris: Agence National d'Accréditation et d'Evaluation en Santé, Edition Frison-Roche.
17. Latvijas Psihiatru Asiciacijas (2001) Sizofrenijas Racionalas Farmakoterpijas Rekomendacijas zalu legades Kompensacijas Sistema. Rija: Latvian Psychiatric Society.
18. Lehman, A. F. & Steinwachs, D. M. (1998) Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin, 24, 1-10.
19. Lehman, A. F., Lieberman, J. A., Dixon, L. B., et al. (2004) Practice guideline for the treatment of patients with schizophrenia, second edition. American Journal of Psychiatry, 161, 1-56.
20. Libiger, J. (1999) Akutní psychotická epizoda. In Psychiatrie. Doporučene Postupy Psychiatrické Péče (Psychiatry, Appropriate Psychiatric Care) (ed. J. Raboch). Prague: Galén, http://www.cls.cz/dp/2002/t285.rtf
21. Lietuvos Respublikos Sveikatos Apsaugos Ministro (2002) Sizofrenijos ir Afektiniu Sutrikiku Gydymo Metodika. Vilnius: Lithuanian Ministry of Health.
22. Marder, S. R., Essock, S. M., Miller, A. L., et al. (2002) The Mount Sinai conference on the pharmacotherapy of schizophrenia. Schizophrenia Bulletin, 28, 5-16.
23. McGorry, P., Killackey, E., Elkins, K., et of (2003) Summary Australasian and New Zealand clinical practice guideline for the treatment of schizophrenia 2003. Australasian Psychiatry, 11, 136-147.
24. McIntyre, J. S. (2002) Usefulness and limitations of treatment of guidelines in psychiatry. World Psychiatry, 1, 186-189.
25. Miller, A. L., Chiles, J. A., Chiles, J. K., et al. (1999) The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms. Journal of Clinical Psychiatry, 60, 649-657.
26. Milner, K. K. & Valenstein, M. (2002) A comparison of guidelines for the treatment of schizophrenia. Psychiatric Services, 53, 888-890.
27. Murray, C. J. L. & Lopez, A. D. (eds) (1996) The Global Burden of Disease. A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard School of Public Health.
28. National Institute for Clinical Excellence (2002) Clinical Guideline I. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. London: NICE.
29. Nordentoft, M., Kelstrup, A., Garde, K., et al. (2001) God Socialpsykiatrisk Standard i Behandlung of Unge og Voksne Med Skizofreni. Denmark: Dansk Psykiatrisk Selskab. (http://www.dadlnet.dk/klaringsrapporter/ 2001-06/2001-06.htm).
30. Patel, V. & Andrade, C. (2003) Pharmacological treatment of severe psychiatric disorders in the developing world: lessons from India. CNS Drugs, 17, 1071-1080.
31. Rutz, W. (2003) The European WHO mental health programme and the World Health Report 2001: input and implications. British Journal of Psychiatry, 183, 73-74.
32. Satokangas, R. K. R. (ed.) (2001) Skitsofrenia. Käypä Hoito-Suositus. Duodecim, 117, 2640-2657. (http://www.duodecim.fi/kh).
33. Sartorius, N., Fleischhacker, W. W., Gjerris, A., et al. (2003) The usefulness and use of second-generation antipsychotic medications - an update. Current Opinion in Psychiatry, 16, S1-S44.
34. Scottish Intercollegiate Guidelines Network (1998) Psychosocial Interventions in the Management of Schizophrenia. Edinburgh: SIGN (http://www.show.scot.nhs.uk/sign/index.html).
35. Singapore Ministry of Health (2003) Schizophrenia. Clinical Practice Guideline. Singapore: Ministry of Health (http://www.moh.gov.sg/cmaweb/ attachments/publication/281cda5elb4e/cpg-schizophrenia.pdf).
36. Sociedad Española de Psiquiatria (2000) Consenso Español de Expertos para Recomendación de Actuación en el Tratamiento de la Esquizofrenia. Madrid: Sociedad Española de Psiquiatria (http://sepsiq.org/Pub/ExpEsq/ExpEsq-1.pdf).
37. Statens Helsetilsyn (2003) Schizofreni. Kliniske Retningslinjer for Utredning og Behandling. Oslo: Norwegian Psychiatric Association and Health Ministry.
38. Stein, D. J., Seedat, S., Niehaus, D. J. H., et al. (2000) Psychiatric Medications in Primary Care: Algorithms and Guidelines. Cape Town: University of Stellenbosch.
39. World Health Organization (1996) Diagnostic and Management Guidelines for Mental Disorders in Primary Care: ICD-10 Chapter V Primary Care Version. Göttingen: Hogrefe & Huber.
40. Zmitek, A., Tavcar, R., Kocmur, M., et al. (2000) Shizofrenija. Priporocila in Smernice za zdradvljenje z zdravili. Ljubljana: Psychiatric Collegium.